Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based …

SMS Khan, MA Qurieshi, I Haq, S Majid, J Ahmad… - BMJ open, 2021 - bmjopen.bmj.com
Objectives We designed a population-based survey in Kashmir to estimate the
seroprevalence of SARS-CoV-2-specific IgG antibodies in the general population aged 18 …

Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India–a cross-sectional study

SMS Khan, MA Qurieshi, I Haq, S Majid, AA Bhat… - PloS one, 2020 - journals.plos.org
Background Prevalence of IgG antibodies against SARS-CoV-2 infection provides essential
information for deciding disease prevention and mitigation measures. We estimate the …

Assessing seropositivity for IgG antibodies against SARS-CoV-2 in Ahmedabad city of India: a cross-sectional study

O Prakash, B Solanki, JK Sheth, B Joshi, M Kadam… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To study the percentage seropositivity for SARS-CoV-2 to understand the
pandemic status and predict the future situations in Ahmedabad. Study design Cross …

Seroprevalence of anti SARS-CoV-2 IgG antibodies among adults in Jammu district, India: A community-based study

D Kumar, M Sidhu, S Dogra, B Kumar… - Indian Journal of …, 2022 - journals.lww.com
Methods On September 30 and October 1, 2020, a household survey was done in 20
villages/wards chosen from 10 health blocks in district Jammu, India. Demographic, clinical …

SARS-CoV-2 antibody seroprevalence in India, August–September, 2020: findings from the second nationwide household serosurvey

MV Murhekar, T Bhatnagar, S Selvaraju… - The Lancet Global …, 2021 - thelancet.com
Background The first national severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) serosurvey in India, done in May–June, 2020, among adults aged 18 years or older from …

COVID-19 seroprevalence in Pakistan: a cross-sectional study

AM Ahmad, K Shahzad, M Masood, M Umar… - BMJ open, 2022 - bmjopen.bmj.com
Objectives This study adapted WHO's 'Unity Study'protocol to estimate the population
prevalence of antibodies to SARS CoV-2 and risk factors for developing SARS-CoV-2 …

Seropositivity of SARS‐CoV‐2 IgG Antibody among People in Dhaka City during the Prevaccination Period

ZB Ahmed, MH Razu, F Akter… - BioMed Research …, 2022 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) immunoglobulin G (IgG)
detection can be an effective complementary tool to the reverse transcription–polymerase …

SARS-CoV-2 antibody prevalence in India: findings from the second nationwide household serosurvey, August-September 2020

MV Murhekar, T Bhatnagar, S Selvaraju… - 2020 - papers.ssrn.com
Background: The first round of national serosurvey in India was conducted in May-June
2020 among adults from 21 States. The second serosurvey was conducted in August …

[HTML][HTML] Seroprevalence of IgG and IgM Antibodies against SARS-CoV-2 Infection in Inhabitants of Itanagar Capital Region, Arunachal Pradesh, India

H Nobin, J Kothapalli, J Moji, S Chauhan, T Yijum… - Maedica, 2023 - ncbi.nlm.nih.gov
Objective: The assessment of novel coronavirus disease 2019 (COVID-19) antibodies is
essential to understand the transmission dynamics of contagious disease. The proportion of …

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

MV Murhekar, T Bhatnagar, S Selvaraju… - Indian Journal of …, 2020 - journals.lww.com
Methods: From May 11 to June 4, 2020, a randomly sampled, community-based survey was
conducted in 700 villages/wards, selected from the 70 districts of the 21 States of India …